TR201710576A2 - A BUFFER FOR ANAL FISSURE TREATMENT WITH A MICROPARTICULAR SYSTEM - Google Patents

A BUFFER FOR ANAL FISSURE TREATMENT WITH A MICROPARTICULAR SYSTEM Download PDF

Info

Publication number
TR201710576A2
TR201710576A2 TR2017/10576A TR201710576A TR201710576A2 TR 201710576 A2 TR201710576 A2 TR 201710576A2 TR 2017/10576 A TR2017/10576 A TR 2017/10576A TR 201710576 A TR201710576 A TR 201710576A TR 201710576 A2 TR201710576 A2 TR 201710576A2
Authority
TR
Turkey
Prior art keywords
buffer
anal fissure
anal
microparticular
fissure treatment
Prior art date
Application number
TR2017/10576A
Other languages
Turkish (tr)
Inventor
Meri̇h Sariişik Ayşe
Yaprak Si̇nem
Rençber Seda
Önder Tolga
Ceylan Türkoğlu Gi̇zem
Original Assignee
Dokuz Eyluel Ueniversitesi Rektoerluegue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dokuz Eyluel Ueniversitesi Rektoerluegue filed Critical Dokuz Eyluel Ueniversitesi Rektoerluegue
Priority to TR2017/10576A priority Critical patent/TR201710576A2/en
Priority to PCT/TR2018/050377 priority patent/WO2019098958A2/en
Priority to EP18877697.5A priority patent/EP3654897A4/en
Publication of TR201710576A2 publication Critical patent/TR201710576A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
    • A61F13/2002—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the use
    • A61F13/2011—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the use specially adapted for anal cavity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/622—Microcapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Buluş, anorektum bölgesi hastalığı anal fissürün medikal tedavisinde kullanılan hemostatik yara iyileştirici biyostabil ve biyobozunur tamponlar ile ilgilidir. Bu anal tamponlar, kalsiyum kanal blokeri ve lokal anestezik özellikli ilaç içermektedir.The invention relates to hemostatic wound healing biostable and biodegradable tampons used in the medical treatment of anorectum area disease anal fissure. These anal tampons contain calcium channel blocker and drug with local anesthetic properties.

TR2017/10576A 2017-07-19 2017-07-19 A BUFFER FOR ANAL FISSURE TREATMENT WITH A MICROPARTICULAR SYSTEM TR201710576A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2017/10576A TR201710576A2 (en) 2017-07-19 2017-07-19 A BUFFER FOR ANAL FISSURE TREATMENT WITH A MICROPARTICULAR SYSTEM
PCT/TR2018/050377 WO2019098958A2 (en) 2017-07-19 2018-07-18 Tampon for anal fissure treatment which comprises a microparticulate system
EP18877697.5A EP3654897A4 (en) 2017-07-19 2018-07-18 TAMPON FOR TREATING ANAL FISSURE WITH A MICROPARTICLE SYSTEM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/10576A TR201710576A2 (en) 2017-07-19 2017-07-19 A BUFFER FOR ANAL FISSURE TREATMENT WITH A MICROPARTICULAR SYSTEM

Publications (1)

Publication Number Publication Date
TR201710576A2 true TR201710576A2 (en) 2019-02-21

Family

ID=66540356

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/10576A TR201710576A2 (en) 2017-07-19 2017-07-19 A BUFFER FOR ANAL FISSURE TREATMENT WITH A MICROPARTICULAR SYSTEM

Country Status (3)

Country Link
EP (1) EP3654897A4 (en)
TR (1) TR201710576A2 (en)
WO (1) WO2019098958A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1127333C (en) * 1997-02-24 2003-11-12 S.L.A.药业股份公司 Topical pharmaceutical composition containing cholinergic agent or calcium channel blocker
BR9815499A (en) * 1997-07-02 2001-01-02 Euro Celtique Sa Prolonged anesthesia in joints and body spaces.
WO2004060447A2 (en) * 2002-12-31 2004-07-22 Ultra-Sonic Technologies, L.L.C. Transdermal delivery using encapsulated agent activated by ultrasound and/or heat
WO2010066203A1 (en) * 2008-12-10 2010-06-17 Anhui Zhongren Technology Co., Ltd. Controlled releasing composition
WO2014127475A1 (en) * 2013-02-19 2014-08-28 Hochman David Jonathan Therapeutic composition for the treatment perianal disorders

Also Published As

Publication number Publication date
WO2019098958A2 (en) 2019-05-23
WO2019098958A3 (en) 2019-08-08
EP3654897A4 (en) 2020-07-15
EP3654897A2 (en) 2020-05-27

Similar Documents

Publication Publication Date Title
EP3613355C0 (en) SURGICAL STAPLE ANVIL WITH TISSUE STOPPING FUNCTIONS TO PREVENT TISSUE PINCHING
BR112013021127B8 (en) Bioabsorbable nasal valve retractor implant device
BR112015027699A2 (en) USE OF ROBENIDINE OR A THERAPEUTICLY ACCEPTABLE SALT THEREOF, ANTIBACTERIAL PHARMACEUTICAL COMPOSITION AND MEDICAL DEVICE
MX2019011117A (en) ANTIBODY B7-H3, ANTIGEN BINDING FRAGMENT OF THE SAME AND MEDICAL USE OF THE SAME.
BR112015027704A2 (en) COMPOUND, USE OF THE SAME AND ANTIBACTERIAL PHARMACEUTICAL COMPOSITION
BR112016002821A2 (en) “ARTICLE FOR TREATMENT OF WOUNDS WITH SUPERABSORBENT FIBERS AND SUPERABSORBENT PARTICLES”
BR112016002781A2 (en) methods and devices for puncturing tissue
BR112015026006A2 (en) methods for treating cancer with the use of tor kinase inhibitor combination therapy
TR201901744T4 (en) Tourmaline-based, sanitary towels for women and urinary incontinence, and gauze / bandages and surgical dressings for treating wounds.
MX380273B (en) ANTIBODY DRUG CONJUGATES (ADCS) WITH KSP INHIBITORS.
MX2016009852A (en) Post-procedure skin care systems, compositions, and methods of use thereof.
MX2020011481A (en) FIXATION DEVICE HAS A STRAP AND INTEGRAL BANDAGE.
BR112015026297A2 (en) combination therapy consisting of a tor kinase inhibitor and a substituted 5-quinazolinone compound for cancer treatment
MX376691B (en) PHARMACEUTICAL COMPOSITION COMPRISING AN IL-4R ANTAGONIST FOR TREATMENT OF A SKIN INFECTION.
MX376410B (en) DEGRADABLE HEMOSTATIC COMPOSITION.
BR112015026247A2 (en) methods for cancer treatment using tor kinase inhibitor combination therapy
MX2015016381A (en) Degradable haemostat composition.
CO7240418A2 (en) Dressing with a prolonged release of active agents
MX2022011790A (en) In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material.
MX2019015676A (en) USE OF ISOVALERIL SPIRAMYCIN I, II AND/OR III IN THE MANUFACTURE OF MEDICINES FOR THE TREATMENT AND/OR PREVENTION OF TUMORS, AND THE MEDICATION.
BR112015023917A2 (en) method for determining activated potentiated form activity of substance
IL290534A (en) Therapeutic systems, devices, and compositions with wound healing and tissue regenerative properties, uses thereof, and corresponding methods
BR112019001130A2 (en) use of lactam and pharmaceutical composition
EA201990995A1 (en) AMSULIPRID POSTOPERATIVE VOMITAL THERAPY
WO2019098958A3 (en) Tampon for anal fissure treatment which comprises a microparticulate system